|
Published by: Datamonitor
Published: Aug. 1, 2008 - 188 Pages
Table of Contents
- Chapter 1 EXECUTIVE SUMMARY
- Summary Market Level - OTC Healthcare
- Summary category level - Analgesics
- Summary category level - Cough and Cold Preparations
- Summary category level - Traditional Medicines
- Summary category level - First Aid Kits
- Summary category level - Indigestion Preparations
- Summary category level - Vitamins and Minerals
- Summary category level - Plasters & Bandages
- Summary category level - Medicated Skin Products
- Summary category level - Other OTC Healthcare Products
- Summary category level - Topical OTC Medicines
- Chapter 2 INTRODUCTION
- What is this report about?
- How to use this report
- Market Definition
- Chapter 3 MARKET OVERVIEW
- Value Analysis, 2001-2006
- Value Analysis, 2006-2011
- Value Analysis, US$ 2001-2006
- Value Analysis, US$ 2006-2011
- Company and Brand Share Analysis
- Expenditure & consumption per capita
- Chapter 4 LEADING COMPANY PROFILES
- Pfizer Inc
- GlaxoSmithKline
- Chapter 5 CATEGORY ANALYSIS - ANALGESICS
- Value Analysis, 2001-2006
- Value Analysis, 2006-2011
- Value Analysis, US$ 2001-2006
- Value Analysis, US$ 2006-2011
- Company and Brand Share Analysis
- Expenditure & consumption per capita
- Chapter 6 CATEGORY ANALYSIS - COUGH AND COLD PREPARATIONS
- Value Analysis, 2001-2006
- Value Analysis, 2006-2011
- Value Analysis, US$ 2001-2006
- Value Analysis, US$ 2006-2011
- Company and Brand Share Analysis
- Expenditure & consumption per capita
- Chapter 7 CATEGORY ANALYSIS - TRADITIONAL MEDICINES
- Value Analysis, 2001-2006
- Value Analysis, 2006-2011
- Value Analysis, US$ 2001-2006
- Value Analysis, US$ 2006-2011
- Company and Brand Share Analysis
- Expenditure & consumption per capita
- Chapter 8 CATEGORY ANALYSIS - FIRST AID KITS
- Value Analysis, 2001-2006
- Value Analysis, 2006-2011
- Value Analysis, US$ 2001-2006
- Value Analysis, US$ 2006-2011
- Company and Brand Share Analysis
- Expenditure & consumption per capita
- Chapter 9 CATEGORY ANALYSIS - INDIGESTION PREPARATIONS
- Value Analysis, 2001-2006
- Value Analysis, 2006-2011
- Value Analysis, US$ 2001-2006
- Value Analysis, US$ 2006-2011
- Company and Brand Share Analysis
- Expenditure & consumption per capita
- Chapter 10 CATEGORY ANALYSIS - VITAMINS AND MINERALS
- Value Analysis, 2001-2006
- Value Analysis, 2006-2011
- Value Analysis, US$ 2001-2006
- Value Analysis, US$ 2006-2011
- Company and Brand Share Analysis
- Expenditure & consumption per capita
- Chapter 11 CATEGORY ANALYSIS - PLASTERS & BANDAGES
- Value Analysis, 2001-2006
- Value Analysis, 2006-2011
- Value Analysis, US$ 2001-2006
- Value Analysis, US$ 2006-2011
- Company and Brand Share Analysis
- Expenditure & consumption per capita
- Chapter 12 CATEGORY ANALYSIS - MEDICATED SKIN PRODUCTS
- Value Analysis, 2001-2006
- Value Analysis, 2006-2011
- Value Analysis, US$ 2001-2006
- Value Analysis, US$ 2006-2011
- Company and Brand Share Analysis
- Expenditure & consumption per capita
- Chapter 13 CATEGORY ANALYSIS - OTHER OTC HEALTHCARE PRODUCTS
- Value Analysis, 2001-2006
- Value Analysis, 2006-2011
- Value Analysis, US$ 2001-2006
- Value Analysis, US$ 2006-2011
- Company and Brand Share Analysis
- Expenditure & consumption per capita
- Chapter 14 CATEGORY ANALYSIS - TOPICAL OTC MEDICINES
- Value Analysis, 2001-2006
- Value Analysis, 2006-2011
- Value Analysis, US$ 2001-2006
- Value Analysis, US$ 2006-2011
- Company and Brand Share Analysis
- Expenditure & consumption per capita
- Chapter 15 COUNTRY COMPARISON
- Value
- Market Share
- Chapter 16 NEW PRODUCT DEVELOPMENT
- Product launches over time
- Recent product launches
- Chapter 17 CANADA SOCIOECONOMIC PROFILE
- Country Overview
- Key Facts
- Political Overview
- Canada Economic Overview
- Chapter 18 CANADA MACROECONOMIC PROFILE
- Macroeconomic Indicators
- Chapter 19 RESEARCH METHODOLOGY
- Methodology overview
- Secondary research
- Market modelling
- Primary research
- Data finalisation
- Ongoing research
- Chapter 20 APPENDIX
- Future readings
- How to contact experts in your industry
- LIST OF FIGURES
- Figure 1: Canada OTC Healthcare value & value forecast, 2001-2011 (CAD m, nominal prices)
- Figure 2: Canada OTC Healthcare category growth comparison, by value, 2001-2011
- Figure 3: Canada OTC Healthcare company share, by value, 2005-2006 (%)
- Figure 4: Canada Analgesics value & value forecast, 2001-2011 (CAD m, nominal prices)
- Figure 5: Canada Analgesics category growth comparison, by value, 2001-2011
- Figure 6: Canada Analgesics company share, by value, 2005-2006 (%)
- Figure 7: Canada Cough and Cold Preparations value & value forecast, 2001-2011 (CAD m, nominal prices)
- Figure 8: Canada Cough and Cold Preparations category growth comparison, by value, 2001-2011
- Figure 9: Canada Cough and Cold Preparations company share, by value, 2005-2006 (%)
- Figure 10: Canada Traditional Medicines value & value forecast, 2001-2011 (CAD m, nominal prices)
- Figure 11: Canada Traditional Medicines company share, by value, 2005-2006 (%)
- Figure 12: Canada First Aid Kits value & value forecast, 2001-2011 (CAD m, nominal prices)
- Figure 13: Canada First Aid Kits company share, by value, 2005-2006 (%)
- Figure 14: Canada Indigestion Preparations value & value forecast, 2001-2011 (CAD m, nominal prices)
- Figure 15: Canada Indigestion Preparations category growth comparison, by value, 2001-2011
- Figure 16: Canada Indigestion Preparations company share, by value, 2005-2006 (%)
- Figure 17: Canada Vitamins and Minerals value & value forecast, 2001-2011 (CAD m, nominal prices)
- Figure 18: Canada Vitamins and Minerals category growth comparison, by value, 2001-2011
- Figure 19: Canada Vitamins and Minerals company share, by value, 2005-2006 (%)
- Figure 20: Canada Plasters & Bandages value & value forecast, 2001-2011 (CAD m, nominal prices)
- Figure 21: Canada Plasters & Bandages category growth comparison, by value, 2001-2011
- Figure 22: Canada Plasters & Bandages company share, by value, 2005-2006 (%)
- Figure 23: Canada Medicated Skin Products value & value forecast, 2001-2011 (CAD m, nominal prices)
- Figure 24: Canada Medicated Skin Products category growth comparison, by value, 2001-2011
- Figure 25: Canada Medicated Skin Products company share, by value, 2005-2006 (%)
- Figure 26: Canada Other OTC Healthcare Products value & value forecast, 2001-2011 (CAD m, nominal prices)
- Figure 27: Canada Other OTC Healthcare Products category growth comparison, by value, 2001-2011
- Figure 28: Canada Other OTC Healthcare Products company share, by value, 2005-2006 (%)
- Figure 29: Canada Topical OTC Medicines value & value forecast, 2001-2011 (CAD m, nominal prices)
- Figure 30: Canada Topical OTC Medicines category growth comparison, by value, 2001-2011
- Figure 31: Canada Topical OTC Medicines company share, by value, 2005-2006 (%)
- Figure 32: Global OTC Healthcare market split (value terms, 2006) - Top 5 countries
- Figure 33: Global OTC Healthcare market value, 2001 - 2006 (Top 5 countries)
- Figure 34: Map of Canada
- Figure 35: Annual data review process
- LIST OF TABLES
- Table 1: OTC Healthcare category definitions
- Table 2: Canada OTC Healthcare value, 2001-2006 (CAD m, nominal prices)
- Table 3: Canada OTC Healthcare value forecast, 2006-2011 (CAD m, nominal prices)
- Table 4: Canada OTC Healthcare value, 2001-2006 (US$ m nominal prices)
- Table 5: Canada OTC Healthcare value forecast, 2006-2011 (US$ m nominal prices)
- Table 6: Canada OTC Healthcare brand share, by value, 2005-2006 (%)
- Table 7: Canada OTC Healthcare value, by brand 2005-2006 (CAD m nominal prices)
- Table 8: Canada OTC Healthcare company share by value, 2005-2006 (%)
- Table 9: Canada OTC Healthcare value, by company, 2005-2006 (CAD m nominal prices)
- Table 10: Canada OTC Healthcare expenditure per capita, 2001-2006 (CAD, nominal prices)
- Table 11: Canada OTC Healthcare forecast expenditure per capita, 2006-2011 (CAD, nominal prices)
- Table 12: Canada OTC Healthcare expenditure per capita, 2001-2006 (US$ nominal prices)
- Table 13: Canada OTC Healthcare forecast expenditure per capita, 2006-2011 (US$ nominal prices)
- Table 14: Pfizer Inc Key Facts
- Table 15: GlaxoSmithKline Key Facts
- Table 16: Canada Analgesics value, 2001-2006 (CAD m, nominal prices)
- Table 17: Canada Analgesics value forecast, 2006-2011 (CAD m, nominal prices)
- Table 18: Canada Analgesics value, 2001-2006 (US$ m nominal prices)
- Table 19: Canada Analgesics value forecast, 2006-2011 (US$ m nominal prices)
- Table 20: Canada Analgesics brand share, by value, 2005-2006 (%)
- Table 21: Canada Analgesics value, by brand 2005-2006 (CAD m nominal prices)
- Table 22: Canada Analgesics company share by value, 2005-2006 (%)
- Table 23: Canada Analgesics value, by company, 2005-2006 (CAD m nominal prices)
- Table 24: Canada Analgesics expenditure per capita, 2001-2006 (CAD, nominal prices)
- Table 25: Canada Analgesics forecast expenditure per capita, 2006-2011 (CAD, nominal prices)
- Table 26: Canada Analgesics expenditure per capita, 2001-2006 (US$ nominal prices)
- Table 27: Canada Analgesics forecast expenditure per capita, 2006-2011 (US$ nominal prices)
- Table 28: Canada Cough and Cold Preparations value, 2001-2006 (CAD m, nominal prices)
- Table 29: Canada Cough and Cold Preparations value forecast, 2006-2011 (CAD m, nominal prices)
- Table 30: Canada Cough and Cold Preparations value, 2001-2006 (US$ m nominal prices)
- Table 31: Canada Cough and Cold Preparations value forecast, 2006-2011 (US$ m nominal prices)
- Table 32: Canada Cough and Cold Preparations brand share, by value, 2005-2006 (%)
- Table 33: Canada Cough and Cold Preparations value, by brand 2005-2006 (CAD m nominal prices)
- Table 34: Canada Cough and Cold Preparations company share by value, 2005-2006 (%)
- Table 35: Canada Cough and Cold Preparations value, by company, 2005-2006 (CAD m nominal prices)
- Table 36: Canada Cough and Cold Preparations expenditure per capita, 2001-2006 (CAD, nominal prices)
- Table 37: Canada Cough and Cold Preparations forecast expenditure per capita, 2006-2011 (CAD, nominal prices)
- Table 38: Canada Cough and Cold Preparations expenditure per capita, 2001-2006 (US$ nominal prices)
- Table 39: Canada Cough and Cold Preparations forecast expenditure per capita, 2006-2011 (US$ nominal prices)
- Table 40: Canada Traditional Medicines value, 2001-2006 (CAD m, nominal prices)
- Table 41: Canada Traditional Medicines value forecast, 2006-2011 (CAD m, nominal prices)
- Table 42: Canada Traditional Medicines value, 2001-2006 (US$ m nominal prices)
- Table 43: Canada Traditional Medicines value forecast, 2006-2011 (US$ m nominal prices)
- Table 44: Canada Traditional Medicines brand share, by value, 2005-2006 (%)
- Table 45: Canada Traditional Medicines value, by brand 2005-2006 (CAD m nominal prices)
- Table 46: Canada Traditional Medicines company share by value, 2005-2006 (%)
- Table 47: Canada Traditional Medicines value, by company, 2005-2006 (CAD m nominal prices)
- Table 48: Canada Traditional Medicines expenditure per capita, 2001-2006 (CAD, nominal prices)
- Table 49: Canada Traditional Medicines forecast expenditure per capita, 2006-2011 (CAD, nominal prices)
- Table 50: Canada Traditional Medicines expenditure per capita, 2001-2006 (US$ nominal prices)
- Table 51: Canada Traditional Medicines forecast expenditure per capita, 2006-2011 (US$ nominal prices)
- Table 52: Canada First Aid Kits value, 2001-2006 (CAD m, nominal prices)
- Table 53: Canada First Aid Kits value forecast, 2006-2011 (CAD m, nominal prices)
- Table 54: Canada First Aid Kits value, 2001-2006 (US$ m nominal prices)
- Table 55: Canada First Aid Kits value forecast, 2006-2011 (US$ m nominal prices)
- Table 56: Canada First Aid Kits brand share, by value, 2005-2006 (%)
- Table 57: Canada First Aid Kits value, by brand 2005-2006 (CAD m nominal prices)
- Table 58: Canada First Aid Kits company share by value, 2005-2006 (%)
- Table 59: Canada First Aid Kits value, by company, 2005-2006 (CAD m nominal prices)
- Table 60: Canada First Aid Kits expenditure per capita, 2001-2006 (CAD, nominal prices)
- Table 61: Canada First Aid Kits forecast expenditure per capita, 2006-2011 (CAD, nominal prices)
- Table 62: Canada First Aid Kits expenditure per capita, 2001-2006 (US$ nominal prices)
- Table 63: Canada First Aid Kits forecast expenditure per capita, 2006-2011 (US$ nominal prices)
- Table 64: Canada Indigestion Preparations value, 2001-2006 (CAD m, nominal prices)
- Table 65: Canada Indigestion Preparations value forecast, 2006-2011 (CAD m, nominal prices)
- Table 66: Canada Indigestion Preparations value, 2001-2006 (US$ m nominal prices)
- Table 67: Canada Indigestion Preparations value forecast, 2006-2011 (US$ m nominal prices)
- Table 68: Canada Indigestion Preparations brand share, by value, 2005-2006 (%)
- Table 69: Canada Indigestion Preparations value, by brand 2005-2006 (CAD m nominal prices)
- Table 70: Canada Indigestion Preparations company share by value, 2005-2006 (%)
- Table 71: Canada Indigestion Preparations value, by company, 2005-2006 (CAD m nominal prices)
- Table 72: Canada Indigestion Preparations expenditure per capita, 2001-2006 (CAD, nominal prices)
- Table 73: Canada Indigestion Preparations forecast expenditure per capita, 2006-2011 (CAD, nominal prices)
- Table 74: Canada Indigestion Preparations expenditure per capita, 2001-2006 (US$ nominal prices)
- Table 75: Canada Indigestion Preparations forecast expenditure per capita, 2006-2011 (US$ nominal prices)
- Table 76: Canada Vitamins and Minerals value, 2001-2006 (CAD m, nominal prices)
- Table 77: Canada Vitamins and Minerals value forecast, 2006-2011 (CAD m, nominal prices)
- Table 78: Canada Vitamins and Minerals value, 2001-2006 (US$ m nominal prices)
- Table 79: Canada Vitamins and Minerals value forecast, 2006-2011 (US$ m nominal prices)
- Table 80: Canada Vitamins and Minerals brand share, by value, 2005-2006 (%)
- Table 81: Canada Vitamins and Minerals value, by brand 2005-2006 (CAD m nominal prices)
- Table 82: Canada Vitamins and Minerals company share by value, 2005-2006 (%)
- Table 83: Canada Vitamins and Minerals value, by company, 2005-2006 (CAD m nominal prices)
- Table 84: Canada Vitamins and Minerals expenditure per capita, 2001-2006 (CAD, nominal prices)
- Table 85: Canada Vitamins and Minerals forecast expenditure per capita, 2006-2011 (CAD, nominal prices)
- Table 86: Canada Vitamins and Minerals expenditure per capita, 2001-2006 (US$ nominal prices)
- Table 87: Canada Vitamins and Minerals forecast expenditure per capita, 2006-2011 (US$ nominal prices)
- Table 88: Canada Plasters & Bandages value, 2001-2006 (CAD m, nominal prices)
- Table 89: Canada Plasters & Bandages value forecast, 2006-2011 (CAD m, nominal prices)
- Table 90: Canada Plasters & Bandages value, 2001-2006 (US$ m nominal prices)
- Table 91: Canada Plasters & Bandages value forecast, 2006-2011 (US$ m nominal prices)
- Table 92: Canada Plasters & Bandages brand share, by value, 2005-2006 (%)
- Table 93: Canada Plasters & Bandages value, by brand 2005-2006 (CAD m nominal prices)
- Table 94: Canada Plasters & Bandages company share by value, 2005-2006 (%)
- Table 95: Canada Plasters & Bandages value, by company, 2005-2006 (CAD m nominal prices)
- Table 96: Canada Plasters & Bandages expenditure per capita, 2001-2006 (CAD, nominal prices)
- Table 97: Canada Plasters & Bandages forecast expenditure per capita, 2006-2011 (CAD, nominal prices)
- Table 98: Canada Plasters & Bandages expenditure per capita, 2001-2006 (US$ nominal prices)
- Table 99: Canada Plasters & Bandages forecast expenditure per capita, 2006-2011 (US$ nominal prices)
- Table 100: Canada Medicated Skin Products value, 2001-2006 (CAD m, nominal prices)
- Table 101: Canada Medicated Skin Products value forecast, 2006-2011 (CAD m, nominal prices)
- Table 102: Canada Medicated Skin Products value, 2001-2006 (US$ m nominal prices)
- Table 103: Canada Medicated Skin Products value forecast, 2006-2011 (US$ m nominal prices)
- Table 104: Canada Medicated Skin Products brand share, by value, 2005-2006 (%)
- Table 105: Canada Medicated Skin Products value, by brand 2005-2006 (CAD m nominal prices)
- Table 106: Canada Medicated Skin Products company share by value, 2005-2006 (%)
- Table 107: Canada Medicated Skin Products value, by company, 2005-2006 (CAD m nominal prices)
- Table 108: Canada Medicated Skin Products expenditure per capita, 2001-2006 (CAD, nominal prices)
- Table 109: Canada Medicated Skin Products forecast expenditure per capita, 2006-2011 (CAD, nominal prices)
- Table 110: Canada Medicated Skin Products expenditure per capita, 2001-2006 (US$ nominal prices)
- Table 111: Canada Medicated Skin Products forecast expenditure per capita, 2006-2011 (US$ nominal prices)
- Table 112: Canada Other OTC Healthcare Products value, 2001-2006 (CAD m, nominal prices)
- Table 113: Canada Other OTC Healthcare Products value forecast, 2006-2011 (CAD m, nominal prices)
- Table 114: Canada Other OTC Healthcare Products value, 2001-2006 (US$ m nominal prices)
- Table 115: Canada Other OTC Healthcare Products value forecast, 2006-2011 (US$ m nominal prices)
- Table 116: Canada Other OTC Healthcare Products brand share, by value, 2005-2006 (%)
- Table 117: Canada Other OTC Healthcare Products value, by brand 2005-2006 (CAD m nominal prices)
- Table 118: Canada Other OTC Healthcare Products company share by value, 2005-2006 (%)
- Table 119: Canada Other OTC Healthcare Products value, by company, 2005-2006 (CAD m nominal prices)
- Table 120: Canada Other OTC Healthcare Products expenditure per capita, 2001-2006 (CAD, nominal prices)
- Table 121: Canada Other OTC Healthcare Products forecast expenditure per capita, 2006-2011 (CAD, nominal prices)
- Table 122: Canada Other OTC Healthcare Products expenditure per capita, 2001-2006 (US$ nominal prices)
- Table 123: Canada Other OTC Healthcare Products forecast expenditure per capita, 2006-2011 (US$ nominal prices)
- Table 124: Canada Topical OTC Medicines value, 2001-2006 (CAD m, nominal prices)
- Table 125: Canada Topical OTC Medicines value forecast, 2006-2011 (CAD m, nominal prices)
- Table 126: Canada Topical OTC Medicines value, 2001-2006 (US$ m nominal prices)
- Table 127: Canada Topical OTC Medicines value forecast, 2006-2011 (US$ m nominal prices)
- Table 128: Canada Topical OTC Medicines brand share, by value, 2005-2006 (%)
- Table 129: Canada Topical OTC Medicines value, by brand 2005-2006 (CAD m nominal prices)
- Table 130: Canada Topical OTC Medicines company share by value, 2005-2006 (%)
- Table 131: Canada Topical OTC Medicines value, by company, 2005-2006 (CAD m nominal prices)
- Table 132: Canada Topical OTC Medicines expenditure per capita, 2001-2006 (CAD, nominal prices)
- Table 133: Canada Topical OTC Medicines forecast expenditure per capita, 2006-2011 (CAD, nominal prices)
- Table 134: Canada Topical OTC Medicines expenditure per capita, 2001-2006 (US$ nominal prices)
- Table 135: Canada Topical OTC Medicines forecast expenditure per capita, 2006-2011 (US$ nominal prices)
- Table 136: Global OTC Healthcare market value, 2006
- Table 137: Global OTC Healthcare market split (value terms (US$ m), 2006) - Top 5 countries
- Table 138: Leading players - Top 5 countries
- Table 139: Canada OTC Healthcare new product launches (reports) and SKUs, by company (Top 5 companies), 2006
- Table 140: Canada OTC Healthcare new product launches (reports), by flavor and fragrances (Top 10 flavors), 2006
- Table 141: Canada OTC Healthcare new product launches (reports), by Ingredients (Top 10 Ingredients), 2006
- Table 142: Canada OTC Healthcare new product launches (reports), by Package tags or Claims (Top 10 claims), 2006
- Table 143: Canada OTC Healthcare new product launches (reports) - Recent 5 launches
- Table 144: Canada Key Facts
- Table 145: Canada population, by age group, 2000-2005 (millions)
- Table 146: Canada population forecast, by age group, 2005-2010 (millions)
- Table 147: Canada population, by gender, 2000-2005 (millions)
- Table 148: Canada population forecast, by gender, 2005-2010 (millions)
- Table 149: Canada real GDP, 2000-2005 (C $ bn, 2005 prices)
- Table 150: Canada real GDP forecast, 2005-2010 (C $ bn, 2005 prices)
- Table 151: Canada nominal GDP, 2000-2005 (C $ bn, nominal prices)
- Table 152: Canada real GDP, 2000-2005 (US$ bn, 2005 prices)
- Table 153: Canada real GDP forecast, 2005-2010 (US$ bn, 2005 prices)
- Table 154: Canada consumer price index, 2000-2005 (2000=100)
- Table 155: Canada consumer price index, 2005-2010 (2000=100)
- Table 156: Canada exchange rate, 2000-2005
AbstractIntroduction
This databook is a detailed information resource covering all the key data points on OTC Healthcare in Canada. It includes comprehensive value volume segmentation and market share data. The databook supplies actual data to 2006 and full forecasts to 2011.
Scope- Contains information on:Analgesics,Cough & cold,Indigestion,Medicated skin products,Traditional medicines,Vitamins & Other OTC healthcare products
- Provides market value, volume, expenditure and consumption data by market, segment and subsegment
- Includes company and brand share data by categories
Highlights
The market for OTC Healthcare in Canada increased between 2001-2006, growing at an average annual rate of 4.3%.
The leading company in the market in 2006 was Pfizer Inc. The second-largest player was GlaxoSmithKline Plc with Jamieson Laboratories in third place.
Reasons to Purchase- Discover the major quantitative trends affecting the OTC Healthcare markets
- Understand consumers' consumption and expenditure patterns
- Understand the future direction of the market with reliable historical data and full five year forecasting
Get Full Details About This Report >>
|
|
US: 800.298.5699
Int'l: +1.240.747.3093
|
|
|